Midazolam vs Osimertinib
Midazolam vs Osimertinib: Overview
This comparison examines the pharmacological differences between Midazolam and Osimertinib.
Mechanism of Action
Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Midazolam — 1.5-2.5 hours; Osimertinib — 48 hours.
Chemical Properties
Molecular Formula: Midazolam — C18H13ClFN3; Osimertinib — C28H33N7O2.
Molecular Weight: Midazolam — 325.7670 g/mol; Osimertinib — 499.6050 g/mol.
Type: Midazolam — Small molecule; Osimertinib — Small molecule.